Pfizer Inc. (PFE) key performance indicators and operating metrics (8 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adjusted diluted earnings per share | 0.75 USD_per_share | FY2026-Q1 |
| Returned to shareholders | 2.4B | FY2026-Q1 |
| Internal R&D | 2.5B | FY2026-Q1 |
| Business development | 110M | FY2026-Q1 |
| Adj. Cost of Sales as a % of revenues | 23.90 percent | FY2025-Q3 |
| Adj. R&D Expenses | 2.5B | FY2025-Q3 |
| Adj. SI&A Expenses | 3.2B | FY2025-Q3 |
| Gross leverage | 2.70 ratio | FY2025-Q3 |
Back to PFE overview · PFE earnings · PFE holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.